Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
Capecitabine-d11, Stable Isotope
Cancer & Cancer Drug
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Chemotherapy
XELODA® - Cancer Therapy Advisor
Frontiers PARP inhibitors combined with radiotherapy: are we ready?
A simplified map of 5-fluorouracil and capecitabine metabolism and
Oxaliplatin, CAS#:63121-00-6
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside
de
por adulto (o preço varia de acordo com o tamanho do grupo)